Getting stem-cell research published in Nature
For advice about how to get your stem cell paper in Nature, senior editor Natalie DeWitt, will answer your questions about how the editorial process works, common misconceptions and other topics in the stem-cell field. Please send Natalie an email containing your question.
Highlights from this month's Nature Reports Stem Cells include:
California stem-cell research: assessing return on investment
Read our commentary by Stanford researcher Michael T. Longaker that explores how Californians can figure out whether its landmark, debt-funded investment in stem-cell research will pay off.
Why are recipients of California stem-cell grants using lines that are eligible for federal funding?
A Nature Reports Stem Cell survey of researchers examines the grants designed to bring new researchers into the stem-cell field.
Bureaucracy blocks work on embryonic stem cells in Japan
Kyoto University's Norio Nakatsuji argues that irrational regulations stifle research in his country.
What experiments should be legal on animal-human chimaeras?
With new legislation covering the use of animal-human chimeras in the works in the United Kingdom, Nature Reports Stem Cells summarizes the report from the UK Academy of Medical Sciences.
Embryonic stem cells for drug discovery
In Nature Reviews Drug Discovery, experts from Monash University describe the advances needed to make assays feasible.
Also read about a survey finding that most fertility patients would donate left-over embryos for stem-cell research and the latest news and views on engineered pluripotent stem cells from Nature.
